In the final quarter of 2025, Fidelity's Retail Class shares for its Mid-Cap Fund demonstrated a notable outperformance, achieving a 3.23% increase. This comfortably surpassed the 1.64% gain registered by the S&P MidCap 400 Index. This period of market activity was characterized by moderate growth across various market capitalizations, accompanied by shifts in sector leadership and two interest rate adjustments by the U.S. Federal Reserve.

A significant factor contributing to the fund's strong showing was its strategic allocation to Coherent. This company emerged as a top individual contributor, with its stock price surging by approximately 71% over the three-month period. This impressive growth was primarily fueled by substantial investments in artificial intelligence infrastructure, highlighting the fund's foresight in identifying high-growth opportunities within emerging technological trends.

Furthermore, the fund benefited considerably from its non-benchmark holding in Exact Sciences. The stock experienced a substantial rally in November following the announcement of Abbott Laboratories' agreement to acquire the cancer-screening firm. This strategic positioning in Exact Sciences further underscored the fund's ability to identify and capitalize on lucrative acquisition targets, enhancing its overall relative returns.

Conversely, certain areas acted as modest impediments to the fund's relative performance. Investments within the consumer discretionary and financial sectors experienced some drag. The decision to avoid Lumentum Holdings, a component of the benchmark index, also negatively impacted the fund's relative results, as Lumentum saw significant gains during the quarter. These instances illustrate the complexities of portfolio management, where even well-considered strategies can face headwinds from specific market segments.

Overall, the Fidelity Mid-Cap Fund's robust performance in the last quarter of 2025 highlights its adept management and strategic investment decisions. The fund successfully navigated a dynamic market environment, leveraging growth opportunities in technology and healthcare, while managing challenges in other sectors. This quarter's results underscore the importance of careful stock selection and diversification in achieving superior investment outcomes.